Correlation Between Unicycive Therapeutics and Dianthus Therapeutics
Can any of the company-specific risk be diversified away by investing in both Unicycive Therapeutics and Dianthus Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Unicycive Therapeutics and Dianthus Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Unicycive Therapeutics and Dianthus Therapeutics, you can compare the effects of market volatilities on Unicycive Therapeutics and Dianthus Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Unicycive Therapeutics with a short position of Dianthus Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Unicycive Therapeutics and Dianthus Therapeutics.
Diversification Opportunities for Unicycive Therapeutics and Dianthus Therapeutics
-0.45 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Unicycive and Dianthus is -0.45. Overlapping area represents the amount of risk that can be diversified away by holding Unicycive Therapeutics and Dianthus Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Dianthus Therapeutics and Unicycive Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Unicycive Therapeutics are associated (or correlated) with Dianthus Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Dianthus Therapeutics has no effect on the direction of Unicycive Therapeutics i.e., Unicycive Therapeutics and Dianthus Therapeutics go up and down completely randomly.
Pair Corralation between Unicycive Therapeutics and Dianthus Therapeutics
Given the investment horizon of 90 days Unicycive Therapeutics is expected to generate 6.67 times less return on investment than Dianthus Therapeutics. But when comparing it to its historical volatility, Unicycive Therapeutics is 4.65 times less risky than Dianthus Therapeutics. It trades about 0.04 of its potential returns per unit of risk. Dianthus Therapeutics is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest 36.00 in Dianthus Therapeutics on September 12, 2024 and sell it today you would earn a total of 2,445 from holding Dianthus Therapeutics or generate 6791.67% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Unicycive Therapeutics vs. Dianthus Therapeutics
Performance |
| Timeline |
| Unicycive Therapeutics |
| Dianthus Therapeutics |
Unicycive Therapeutics and Dianthus Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Unicycive Therapeutics and Dianthus Therapeutics
The main advantage of trading using opposite Unicycive Therapeutics and Dianthus Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Unicycive Therapeutics position performs unexpectedly, Dianthus Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Dianthus Therapeutics will offset losses from the drop in Dianthus Therapeutics' long position.| Unicycive Therapeutics vs. Transcode Therapeutics | Unicycive Therapeutics vs. Cardio Diagnostics Holdings |
| Dianthus Therapeutics vs. Hudson Pacific Properties | Dianthus Therapeutics vs. NETGEAR | Dianthus Therapeutics vs. Eastern Co | Dianthus Therapeutics vs. Weibo Corp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
Other Complementary Tools
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account |